Raising awareness of the benefits of biosimilars in the UK
Highlights from EBMT 2016: Immunotherapy
iwNHL 2015 roundtable: Day 2 highlights – CAR T-cell therapy for non-Hodgkin lymphoma
John Gribben et al.
Why do charities need to keep funding research into leukemia and blood cancer in general?
The role of blinatumomab in ALL